Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("MOLONEY LEUKEMIA")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 41

  • Page / 2
Export

Selection :

  • and

TREATMENT OF MURINE TUMORS WITH LETHAL DOSES OF DIMETHYLMYLERAN AND AUTOLOGOUS BONE MARROWFLOERSHEIM GL.1981; EUR. J. CANCER CLIN. ONCOL.; GBR; DA. 1981; VOL. 17; NO 8; PP. 905-912; BIBL. 22 REF.Article

IMMUNE RESPONSES TO WEAKLY IMMUNOGENIC VIRALLY INDUCED TUMORS. I. OVERCOMING LOW RESPONSIVENESS BY PRIMING MICE WITH A SYNGENEIC IN VITRO TUMOR LINE OR ALLOGENEIC CROSS-REACTIVE TUMOR.GALILI N; DEVENS B; NAOR D et al.1978; EUROP. J. IMMUNOL.; GERM.; DA. 1978; VOL. 8; NO 1; PP. 17-22; BIBL. 32 REF.Article

ROLE OF NON-CONVENTIONAL NATURAL KILLER CELLS IN RESISTANCE AGAINST SYNGENEIC TUMOUR CELLS IN VIVO.HALLER O; HANSSON M; KIESSLING R et al.1977; NATURE; G.B.; DA. 1977; VOL. 270; NO 5638; PP. 609-611; BIBL. 19 REF.Article

Inhibition of the synthesis of Moloney leukemia virus structural proteins by N-methylisatin-β-4'-4'-diethylthiosemicarbazoneRONEN, D; TEITZ, Y.Antimicrobial agents and chemotherapy. 1984, Vol 26, Num 6, pp 913-916, issn 0066-4804Article

A CYTOENZYMATIC STUDY ON MURINE LYMPHOBLASTIC LYMPHATIC LEUKAEMIASDAS S; BASU A; CHATTERJEE A et al.1978; TUMOR RES.; JPN; DA. 1978; VOL. 13; PP. 31-39; BIBL. 36 REF.Article

GENETIC CONTROL OF SENSITIVITY TO MOLONEY LEUKEMIA VIRUS IN MICE. II: MAPPING OF THREE RESISTANT GENES WITHIN THE H-2 COMPLEXDEBRE P; GISSELBRECHT S; POZO F et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 4; PP. 1806-1812; BIBL. 31 REF.Article

A THYMUS CELL MARKER IN MURINE LEUKEMIA VIRUS-INDUCED LYMPHOMAS OF RATSTAKEICHI N; SUZUKI K; KOBAYASHI H et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 9; PP. 3749-3751; BIBL. 18 REF.Article

TRANSPLANTATION RESISTANCE OF DRUG-TREATED ALLOGENEIC MICE AGAINST MURINE LYMPHOMAS. II: STUDIES WITH VARIOUS TUMOR-HOST COMBINATIONSBONMASSAR A; RIVOSECCHI MERLETTI P; BARZI A et al.1981; INT. J. IMMUNOPHARMACOL.; ISSN 0192-0561; USA; DA. 1981; VOL. 3; NO 4; PP. 391-399; BIBL. 2 P.Article

COLUMN SELECTION OF ANTIGENIC VARIANTS FROM TUMORS. YAC (MOLONEY) LYMPHOMA VARIANTS WITH REDUCED ANTIGEN EXPRESSIONDALIANIS T; KLEIN G; ANDERSSON B et al.1979; IMMUNOGENETICS; DEU; DA. 1979; VOL. 9; NO 4-5; PP. 465-475; BIBL. 13 REF.Article

SECONDARY CYTOTOXIC RESPONSE IN VITRO AGAINST MOLONEY LYMPHOMA CELLS ANTIGENICALLY ALTERED BY DRUG TREATMENT IN VIVO.SANTONI A; KINNEY Y; GOLDIN A et al.1978; J. NATION. CANCER INST.; U.S.A.; DA. 1978; VOL. 60; NO 1; PP. 109-112; BIBL. 12 REF.Article

THE ROLE OF THE PERITONEAL CAVITY IN SUCCESFUL TREATMENT OF A MURINE LYMPHOMA WITH CHEMOTHERAPY AND NON-SPECIFIC IMMUNOSTIMULATIONMARCONI P; BISTONI F; CASSONE A et al.1982; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1982; VOL. 13; NO 2; PP. 128-133; BIBL. 17 REF.Article

IMMUNOSUPPRESSION BY SPLEEN CELLS FROM MOLONEY LEUKEMIA. III. EVIDENCE FOR A SUPPRESSOR CELL THAT IS NOT THE LEUKEMIC, VIRUS-PRODUCING CELL.CERNY J; GRINWICH KD; STILLER RA et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 3; PP. 1097-1101; BIBL. 21 REF.Article

IMMUNOLOGIC MECHANISMS IN THE PATHOGENESIS OF VIRUS-INDUCED MURINE LEUKEMIA. III. TARGET CELL SPECIFICITY OF AUTOREACTIVE THYMOCYTES.PROFFITT MR; HIRSCH MS; ELLIS DA et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 1; PP. 11-15; BIBL. 19 REF.Article

IMMUNIZATION OF MICE WITH SYNGENEIC MOLONEY LYMPHOMA CELLS INDUCES SEPARATE ANTIBODIES GAMMA AGAINST VIRION ENVELOPE GLYCOPROTEIN AND VIRUS-INDUCED CELL SURFACE ANTIGENS.FENYO EM; YEFENOF E; KLEIN E et al.1977; J. EXPER. MED.; U.S.A.; DA. 1977; VOL. 146; NO 6; PP. 1521-1533; BIBL. 1 P. 1/2Article

MOLONEY LYMPHOMA CELLS EXPRESS A POLYPROTEIN CONTAINING THE GAG GENE-CODED P15 AND THE MOLONEY LEUKEMIA VIRUS INDUCED CELL SURFACE ANTIGEN (MCSA)KARANDE A; YEFENOF E; FENYO EM et al.1979; INTERNATION. J. CANCER; CHE; DA. 1979; VOL. 23; NO 4; PP. 508-513; ABS. FREArticle

SECONDARY IN VITRO GENERATION OF CYTOLYTIC. T-LYMPHOCYTES (CTL'S) IN THE MURINE SARCOMA VIRUS SYSTEM: VIRUS SPECIFIC CTL INDUCTION ACROSS THE H-2-BARRIERCOLLAVO D; PARENTI A; BIASI G et al.1978; J. NATION. CANCER. INST.; USA; DA. 1978; VOL. 61; NO 3; PP. 885-890; BIBL. 28 REF.Article

IMMUNOSUPPRESSION BY SPLEEN CELLS FROM MOLONEY LEUKEMIA. II. STUDIES ON THE MECHANISM OF SUPPRESSION AND FAILURE TO DETECT AN EXTRACELLULAR SUPRESSIVE PRODUCT.STILLER RA; CERNY J.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 3; PP. 889-899; BIBL. 32 REF.Article

Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activitySHU-CHEN CHU; YIH-SHOU HSIEH; JUNG-YAW LIN et al.Journal of natural products (Print). 1992, Vol 55, Num 2, pp 179-183, issn 0163-3864Article

Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coliJONSSON, C. B; DONZELLA, G. A; ROTH, M. J et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 2, pp 1462-1469, issn 0021-9258Article

Effect of subordinance, lack of social hierarchy, and restricted feeding on murine survival and virus leukemiaEBBESEN, P; VILLADSEN, J. A; VILLADSEN, H. D et al.Experimental gerontology. 1991, Vol 26, Num 5, pp 479-486, issn 0531-5565Article

Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors = Purification d'une glycoprotéine portant un antigène de transplantation associé aux tumeurs, spécifique des tumeurs induites par les virus des leucémies murines de Friend, Moloney et RauscherROGERS, M. J; GALETTO, G; HEARING, V. J et al.The Journal of immunology (1950). 1984, Vol 132, Num 6, pp 3211-3217, issn 0022-1767Article

Relationships among tumor load, route of tumor inoculation, and response to immunochemotherapy in a murine lymphoma model = Relations entre la charge tumorale, la voie d'inoculation d'une tumeur et la réponse à l'immunochimie thérapie dans un modèle de lymphome murinMARCONI, P; CASSONE, A; BACCARINI, M et al.Journal of the National Cancer Institute. 1983, Vol 71, Num 2, pp 299-307, issn 0027-8874Article

Temporal lymphoreticular changes caused by ts1, a paralytogenic mutant of moloney murine leukemia virus TBSTOICA, G; FLOYD, E; ILLANES, O et al.Laboratory investigation. 1992, Vol 66, Num 4, pp 427-436, issn 0023-6837Article

APPEARANCE AND DISTRIBUTION OF VIRALLY DETERMINED ANTIGENS IN LYMPHOID ORGANS OF MICE DURING LEUKEMOGENESIS BY MOLONEY LEUKEMIA VIRUSASJOE B; FENYOE EM; SPIRA J et al.1980; LEUKEMIA RES.; GBR; DA. 1980; VOL. 4; NO 1; PP. 89-103; BIBL. 31 REF.Article

CELL-MEDIATED REACTIVITY TO ANTIGENS SHARED BY MOLONEY VIRUS INDUCED LYMPHOMAS (LSTRA) AND CERTAIN 3-METHYL-CHOLANTHRENE-INDUCED MOUSE SARCOMASHELLSTROM I; HELLSTROM KE; ZEIDMAN L et al.1979; INTERNATION. J. CANCER; CHE; DA. 1979; VOL. 23; NO 4; PP. 555-564; ABS. FRE; BIBL. 22 REF.Article

  • Page / 2